Thymic tumorigenesis induced by overexpression of p56lck - PubMed (original) (raw)

Thymic tumorigenesis induced by overexpression of p56lck

K M Abraham et al. Proc Natl Acad Sci U S A. 1991.

Abstract

The lck gene encodes a membrane-associated protein tyrosine kinase (p56lck) that is believed to participate in lymphocyte-specific signal transduction pathways. To investigate the function of this molecule, transgenic mice were generated carrying the wild-type lck gene or a mutated lck gene encoding a constitutively activated form of p56lck (p56lckF505). Transgene expression in thymocytes was achieved in each case using the lck proximal promoter element. Mice expressing high levels of either p56lckF505 or p56lckY505 reproducibly developed thymic tumors. The sensitivity of thymocytes to p56lck-induced transformation suggests that disturbances in lck expression may contribute to the pathogenesis of some human neoplastic diseases.

PubMed Disclaimer

Similar articles

• Delayed thymocyte development induced by augmented expression of p56lck.
  Abraham KM, Levin SD, Marth JD, Forbush KA, Perlmutter RM. Abraham KM, et al. J Exp Med. 1991 Jun 1;173(6):1421-32. doi: 10.1084/jem.173.6.1421. J Exp Med. 1991. PMID: 1709675 Free PMC article.
• Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen.
  Garvin AM, Abraham KM, Forbush KA, Farr AG, Davison BL, Perlmutter RM. Garvin AM, et al. Int Immunol. 1990;2(2):173-80. doi: 10.1093/intimm/2.2.173. Int Immunol. 1990. PMID: 1965144
• Decreased signaling competence as a result of receptor overexpression: overexpression of CD4 reduces its ability to activate p56lck tyrosine kinase and to regulate T-cell antigen receptor expression in immature CD4+CD8+ thymocytes.
  Nakayama T, Wiest DL, Abraham KM, Munitz TI, Perlmutter RM, Singer A. Nakayama T, et al. Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10534-8. doi: 10.1073/pnas.90.22.10534. Proc Natl Acad Sci U S A. 1993. PMID: 7902564 Free PMC article.
• The lymphocyte-specific tyrosine protein kinase p56lck.
  Abraham N, Veillette A. Abraham N, et al. Cancer Invest. 1991;9(4):455-63. doi: 10.3109/07357909109084644. Cancer Invest. 1991. PMID: 1832077 Review. No abstract available.
• CD4, CD8 and tyrosine kinases in thymic selection.
  Wallace VA, Penninger J, Mak TW. Wallace VA, et al. Curr Opin Immunol. 1993 Apr;5(2):235-40. doi: 10.1016/0952-7915(93)90010-p. Curr Opin Immunol. 1993. PMID: 8507400 Review.

Cited by

• A novel animal model of thymic tumour: development of epithelial thymoma in transgenic rats carrying human T lymphocyte virus type I pX gene.
  Kikuchi K, Ikeda H, Tsuchikawa T, Tsuji T, Tanaka S, Fugo K, Sugaya T, Tanaka Y, Tateno M, Maruyama N, Yoshiki T. Kikuchi K, et al. Int J Exp Pathol. 2002 Oct;83(5):247-55. doi: 10.1046/j.1365-2613.2003.00233.x. Int J Exp Pathol. 2002. PMID: 12641821 Free PMC article.
• Ntk: a Csk-related protein-tyrosine kinase expressed in brain and T lymphocytes.
  Chow LM, Jarvis C, Hu Q, Nye SH, Gervais FG, Veillette A, Matis LA. Chow LM, et al. Proc Natl Acad Sci U S A. 1994 May 24;91(11):4975-9. doi: 10.1073/pnas.91.11.4975. Proc Natl Acad Sci U S A. 1994. PMID: 8197166 Free PMC article.
• Overexpression of RhoH Permits to Bypass the Pre-TCR Checkpoint.
  Tamehiro N, Oda H, Shirai M, Suzuki H. Tamehiro N, et al. PLoS One. 2015 Jun 26;10(6):e0131047. doi: 10.1371/journal.pone.0131047. eCollection 2015. PLoS One. 2015. PMID: 26114424 Free PMC article.
• Transcriptional activation of known and novel apoptotic pathways by Nur77 orphan steroid receptor.
  Rajpal A, Cho YA, Yelent B, Koza-Taylor PH, Li D, Chen E, Whang M, Kang C, Turi TG, Winoto A. Rajpal A, et al. EMBO J. 2003 Dec 15;22(24):6526-36. doi: 10.1093/emboj/cdg620. EMBO J. 2003. PMID: 14657025 Free PMC article.
• Phospho-Specific Flow Cytometry Reveals Signaling Heterogeneity in T-Cell Acute Lymphoblastic Leukemia Cell Lines.
  Perbellini O, Cavallini C, Chignola R, Galasso M, Scupoli MT. Perbellini O, et al. Cells. 2022 Jun 29;11(13):2072. doi: 10.3390/cells11132072. Cells. 2022. PMID: 35805156 Free PMC article.

References

1. 1. Int Immunol. 1990;2(2):173-80 - PubMed
2. 1. Biochemistry. 1979 Nov 27;18(24):5294-9 - PubMed
3. 1. Nature. 1991 Jan 17;349(6306):241-3 - PubMed
4. 1. J Exp Med. 1991 Jan 1;173(1):89-100 - PubMed
5. 1. Proc Natl Acad Sci U S A. 1988 Feb;85(3):836-40 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • GlyGen glycoinformatics resource
  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal